Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VVUS: VIVUS INC. (NASDAQ) -- Ignore unavailable to you. Want to Upgrade?

To: VLAD who wrote (6752)	4/9/1998 7:07:00 PM
From: LoLoLoLita	Respond to of 23519

VLAD, I agree that VVUS is probably dead money for the next few months, and will probably stay around 10 based on the many bounces off support in the upper 9s. The only possible reason that i can see for it going lower was if some really bad news came out. i'm truly baffled as to why they supported the stock at its near-term high! It just strikes me as idiotic. And i'll go out on a limb, and say that this issue could be the basis for a whole new round of class-action suits, which i might be tempted to join, because if VVUS really did buy back all those shares at $14.75, they are morons, and failed miserably in their mandate to protect shareholder interests. Companies should be investing in their own shares; that is, buying them when they are cheap, not speculating by buying on momentum and trying to force short-squeezes. The obvious buy point since last December was 10 or high 9s. For now, i'm happy to sit on the fence and see what happens. There is a place for MUSE in the pharmacopeia--and Janssen and Astra are not stupid; they have surely invested quite a bit in their DD. But, on the other hand, any inclination i have to buy back in on the dips and try to scalp it for a point or two is quashed by this new development on the buy-back program. David